Interaction of tRNA with MEK2 in pancreatic cancer cells

about

Modifications and functional genomics of human transfer RNA.The dysregulation of tRNAs and tRNA derivatives in cancer.

P2860

Q49788974-8730AF09-A2EB-4AB9-80C8-6DB2CB5B8C2F Q53823804-638FFA87-568E-4A53-8D21-16807F716CDA

P2860

Interaction of tRNA with MEK2 in pancreatic cancer cells

Item

http://www.wikidata.org/entity/Q37006130

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interaction of tRNA with MEK2 in pancreatic cancer cells

@en

Interaction of tRNA with MEK2 in pancreatic cancer cells.

@nl

type

Item

label

Interaction of tRNA with MEK2 in pancreatic cancer cells

@en

Interaction of tRNA with MEK2 in pancreatic cancer cells.

@nl

prefLabel

Interaction of tRNA with MEK2 in pancreatic cancer cells

@en

Interaction of tRNA with MEK2 in pancreatic cancer cells.

@nl

P1476

Interaction of tRNA with MEK2 in pancreatic cancer cells

@en

P2093

Hidayatullah G Munshi

http://www.w3.org/2001/XMLSchema#string

Jiyoung Lee

http://www.w3.org/2001/XMLSchema#string

Kazumi Ebine

http://www.w3.org/2001/XMLSchema#string

Marsha R Rosner

http://www.w3.org/2001/XMLSchema#string

Tao Pan

http://www.w3.org/2001/XMLSchema#string

Xiaoyun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11

tRNA binding, structure, and localization of the human interferon-induced protein IFIT5

Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data

The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.

Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2

CLIP: a method for identifying protein-RNA interaction sites in living cells

Discovering RNA-protein interactome by using chemical context profiling of the RNA-protein interface

P2888

srep28260

P304

28260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP28260

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christina R Chow

P577

2016-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27301426

http://www.w3.org/2001/XMLSchema#string

P932

4908586

http://www.w3.org/2001/XMLSchema#string

Interaction of tRNA with MEK2 in pancreatic cancer cells

about

P2860

P2860

Interaction of tRNA with MEK2 in pancreatic cancer cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932